Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors in the central anxious procedure, conolidine modulates alternate molecular targets. A Science Advances research identified that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availability. By https://conolidineforanklepainaft26889.mybloglicious.com/57752339/examine-this-report-on-alternative-natural-pain-relief-to-replace-traditional-painkillers